Medicine and Dentistry
Adverse Event
20%
Afferent Pupillary Defect
12%
Aflibercept
58%
Age Related Macular Degeneration
59%
Agents Acting on the Eye
93%
Aneurysm
11%
Arteritic Anterior Ischemic Optic Neuropathy
15%
Best Corrected Visual Acuity
49%
Bevacizumab
12%
Biological Marker
12%
Biopsy Technique
23%
Bleeding
14%
Brachytherapy
12%
Brolucizumab
19%
Cataract
13%
Cataract Surgery
12%
Cavernous Sinus
12%
Choroid Melanoma
11%
Choroidal Neovascularization
19%
Clinical Feature
11%
Clinical Trial
25%
Clinician
20%
COVID-19
17%
Diabetic Macular Edema
63%
Diabetic Retinopathy
63%
Diagnosis
14%
Diplopia
18%
Disease
11%
Diseases
49%
Edema
13%
Endophthalmitis
29%
Endothelial Cell Growth Factor
10%
English (Language)
12%
Epiretinal Membrane
12%
Fenestration
13%
Flight
18%
Fluorescein
11%
Fluorescein Angiography
35%
Gene Expression
12%
Geographic Atrophy
17%
Giant-Cell Arteritis
29%
Headache
17%
Idiopathic Intracranial Hypertension
26%
Intracranial Hypertension
12%
Intracranial Pressure
11%
Intraocular Lens
16%
Intraocular Pressure
14%
Intravitreal Administration
21%
Ischemic Optic Neuropathy
14%
Laser Coagulation
26%
Macular Edema
28%
Macular Hole
26%
Maculopathy
14%
Magnetic Resonance Imaging
26%
Medicine
13%
Meta-Analysis
20%
Metastatic Carcinoma
10%
Neoplasm
44%
Nerve Sheath
27%
Neuro-Ophthalmology
38%
Ophthalmology
47%
Ophthalmoparesis
19%
Optic Disc
14%
Optic Nerve
60%
Optic Neuritis
13%
Optic Neuropathy
28%
Optical Coherence Tomography
62%
Papilledema
40%
Pars Plana Vitrectomy
26%
Pathophysiology
13%
Post-Hoc Analysis
11%
Proliferative Diabetic Retinopathy
22%
Radiation Therapy
15%
Randomized Clinical Trial
14%
Ranibizumab
46%
Recurrent Disease
11%
Retina Vein Occlusion
18%
Retinal Detachment
47%
Retinal Pigment Epithelium
15%
Retinoblastoma
21%
Retinopathy
12%
Retinopathy of Prematurity
23%
Scleral Buckle
14%
Spectral Domain Optical Coherence Tomography
19%
Subretinal Fluid
13%
Surgeon
12%
Surgery
27%
Systematic Review
15%
Telangiectasia
11%
Triamcinolone Acetonide
13%
Uvea Melanoma
36%
Uveitis
14%
Vasculotropin
56%
Vision
12%
Visual Acuity
100%
Visual Field
20%
Visual Impairment
63%
Vitrectomy
32%
Vitreous
20%
Wet Macular Degeneration
58%
Keyphrases
Adverse Events
5%
Aflibercept
19%
Age-related Macular Degeneration
8%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
7%
Anti-vascular Endothelial Growth Factor Therapy
6%
Anti-VEGF Therapy
9%
Best-corrected Visual Acuity
19%
Bevacizumab
6%
Brolucizumab
15%
Central Subfield Thickness
7%
Clinical Trials
5%
Confidence Interval
6%
Diabetic Macular Edema
26%
Diabetic Retinopathy
14%
Diabetic Retinopathy Grading
5%
Early Treatment Diabetic Retinopathy Study
6%
ETDRS
5%
Faricimab
5%
Giant Cell Arteritis
12%
Headache
5%
Idiopathic Intracranial Hypertension
6%
Intravitreal
6%
Intravitreal Aflibercept
14%
Intravitreal Aflibercept Injection
15%
Intravitreal Injection
5%
Macular Edema
11%
Macular Star
5%
Magnetic Resonance Imaging
5%
Neovascular Age-related Macular Degeneration (nAMD)
29%
Neuro-ophthalmology
24%
Neuroretinitis
6%
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
7%
Ocular Side Effects
5%
Ophthalmic Diseases
5%
Ophthalmologist
16%
Ophthalmology
12%
Optic Disc Edema
13%
Optic Nerve
5%
Optical Coherence Tomography
8%
Pars Plana Vitrectomy
6%
Proliferative Diabetic Retinopathy
7%
Randomized Trial
7%
Ranibizumab
15%
Retina
6%
Retinal Nonperfusion
5%
Retinal Thickness
5%
Retinal Vein Occlusion
7%
Retinopathy of Prematurity
5%
Rhegmatogenous Retinal Detachment
8%
Right Eye
9%
Spaceflight Associated Neuro-ocular Syndrome
9%
Spectral Domain Optical Coherence Tomography (SD-OCT)
5%
Subretinal Fluid
8%
Suprachoroidal
5%
Third Cranial Nerve Palsy
5%
Treat-and-extend
7%
Treatment Options
5%
Ultra-high Field
5%
Uveal Melanoma
10%
Vision Loss
9%
Visual Acuity
15%
Visual Acuity Outcome
5%
Visual Loss
9%
Visual Outcome
6%